Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
HY

NASDAQ · HYFT

MindWalk Holdings Corp.

Healthcare · Biotechnology

$1.31

Down-$0.02 (-1.14%)

Updated Sep 14, 2026, 6:30 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
86.77M
P/E ratio
-4.09
Dividend yield
0.00%
52-week range
$0.99 – $1.99
Volume
74.73K
Avg. volume
759.84K

Price performance

HYFT price history

1M range · 19 trading sessions · Daily adjusted prices

HYFT closed at $1.31 after 19 trading sessions, down 1.88% for the selected period.

Last close
$1.31
Period change
-1.88%
Period low
$1.29
Period high
$1.45
Daily close
View OHLC price history
HYFT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 11, 2026$1.32$1.34$1.30$1.30574.73K
Sep 10, 2026$1.29$1.32$1.28$1.3270.14K
Sep 9, 2026$1.34$1.35$1.28$1.29155.33K
Sep 8, 2026$1.32$1.35$1.279$1.35161.77K
Sep 4, 2026$1.31$1.3845$1.30$1.3291.94K
Sep 3, 2026$1.34$1.389$1.31$1.3388.71K
Sep 2, 2026$1.30$1.3662$1.30$1.33557.8K
Sep 1, 2026$1.30$1.335$1.27$1.3080.51K
Aug 31, 2026$1.37$1.39$1.32$1.3455.68K
Aug 28, 2026$1.44$1.44$1.3801$1.3973.72K
Aug 27, 2026$1.43$1.44$1.40$1.4249.35K
Aug 26, 2026$1.42$1.44$1.37$1.4384.57K
Aug 25, 2026$1.39$1.43$1.39$1.42120.58K
Aug 24, 2026$1.39$1.41$1.33$1.3879.5K
Aug 21, 2026$1.37$1.42$1.3601$1.4173.5K
Aug 20, 2026$1.44$1.4493$1.3601$1.3782.35K
Aug 19, 2026$1.33$1.50$1.2893$1.45204.15K
Aug 18, 2026$1.30$1.372$1.25$1.33175.9K
Aug 17, 2026$1.40$1.41$1.31$1.33214.12K

Latest HYFT news

The latest Smart Investors Daily articles mentioning HYFT.

Stock researchCompany · Overview

HYFT research

Overview

Company profile and research snapshot.

Company profile

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
HYFT recent ratings
DateFirmRatingTarget
May 19, 2026HC Wainwright & Co.Buy—
Apr 16, 2026Jones TradingBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 8, 2026

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

AUSTIN, Texas, September 08, 2026--MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the first quarter of fiscal year 2027 and host a conference call on Monday, September 14, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.

Yahoo · Sep 3, 2026

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery market at approximately $1.71 billion in 2024 and projects it will reach roughly $8.52 billion by 2030, a compound annual growth rate of about 30.58%. That is a market compounding at more than double the rate of most enterprise software categories, and it is being spent inside an industry that already inves

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By